Analysts Set Henry Schein, Inc. (NASDAQ:HSIC) Target Price at $81.10

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have been assigned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the company, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $81.10.

HSIC has been the subject of a number of recent research reports. Barrington Research reiterated an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a research report on Wednesday, February 26th. Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. UBS Group dropped their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd.

Insider Buying and Selling at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of HSIC. Palestra Capital Management LLC purchased a new stake in Henry Schein during the 4th quarter worth approximately $182,988,000. Lyrical Asset Management LP acquired a new position in shares of Henry Schein during the fourth quarter valued at $126,655,000. Norges Bank bought a new stake in shares of Henry Schein during the fourth quarter valued at approximately $103,301,000. Steadfast Capital Management LP boosted its position in Henry Schein by 254.2% during the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock worth $113,336,000 after acquiring an additional 1,175,408 shares during the period. Finally, Holocene Advisors LP bought a new position in Henry Schein in the 3rd quarter valued at about $58,319,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Down 1.1 %

Henry Schein stock opened at $68.62 on Thursday. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The business’s 50-day simple moving average is $74.62 and its two-hundred day simple moving average is $72.64. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market cap of $8.52 billion, a PE ratio of 28.24, a PEG ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company’s revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.66 earnings per share. Equities analysts anticipate that Henry Schein will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.